458 related articles for article (PubMed ID: 21075971)
1. The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis.
Pender MP
Neuroscientist; 2011 Aug; 17(4):351-67. PubMed ID: 21075971
[TBL] [Abstract][Full Text] [Related]
2. Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection.
Pender MP
Autoimmun Rev; 2009 Jun; 8(7):563-8. PubMed ID: 19254880
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
Serafini B; Rosicarelli B; Veroni C; Mazzola GA; Aloisi F
J Virol; 2019 Dec; 93(24):. PubMed ID: 31578295
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus in multiple sclerosis.
Bagert BA
Curr Neurol Neurosci Rep; 2009 Sep; 9(5):405-10. PubMed ID: 19664371
[TBL] [Abstract][Full Text] [Related]
5. Epstein-barr virus infection and multiple sclerosis: a review.
Ascherio A; Munger KL
J Neuroimmune Pharmacol; 2010 Sep; 5(3):271-7. PubMed ID: 20369303
[TBL] [Abstract][Full Text] [Related]
6. The interaction of Multiple Sclerosis risk loci with Epstein-Barr virus phenotypes implicates the virus in pathogenesis.
Afrasiabi A; Parnell GP; Swaminathan S; Stewart GJ; Booth DR
Sci Rep; 2020 Jan; 10(1):193. PubMed ID: 31932685
[TBL] [Abstract][Full Text] [Related]
7. The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis.
Veroni C; Aloisi F
Front Immunol; 2021; 12():665718. PubMed ID: 34305896
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain.
Willis SN; Stadelmann C; Rodig SJ; Caron T; Gattenloehner S; Mallozzi SS; Roughan JE; Almendinger SE; Blewett MM; Brück W; Hafler DA; O'Connor KC
Brain; 2009 Dec; 132(Pt 12):3318-28. PubMed ID: 19638446
[TBL] [Abstract][Full Text] [Related]
9. The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review.
Ruprecht K
Expert Rev Clin Immunol; 2020 Dec; 16(12):1143-1157. PubMed ID: 33152255
[No Abstract] [Full Text] [Related]
10. Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies.
Fernández-Menéndez S; Fernández-Morán M; Fernández-Vega I; Pérez-Álvarez A; Villafani-Echazú J
J Neurol Sci; 2016 Feb; 361():213-9. PubMed ID: 26810546
[TBL] [Abstract][Full Text] [Related]
11. Strains of Epstein-Barr virus infecting multiple sclerosis patients.
Brennan RM; Burrows JM; Bell MJ; Bromham L; Csurhes PA; Lenarczyk A; Sverndal J; Klintenstedt J; Pender MP; Burrows SR
Mult Scler; 2010 Jun; 16(6):643-51. PubMed ID: 20350958
[TBL] [Abstract][Full Text] [Related]
12. CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis.
Pender MP
Autoimmune Dis; 2012; 2012():189096. PubMed ID: 22312480
[TBL] [Abstract][Full Text] [Related]
13. The Interaction between Viral and Environmental Risk Factors in the Pathogenesis of Multiple Sclerosis.
Tarlinton RE; Khaibullin T; Granatov E; Martynova E; Rizvanov A; Khaiboullina S
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646507
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus and multiple sclerosis.
Pohl D
J Neurol Sci; 2009 Nov; 286(1-2):62-4. PubMed ID: 19361810
[TBL] [Abstract][Full Text] [Related]
15. Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis.
Vietzen H; Berger SM; Kühner LM; Furlano PL; Bsteh G; Berger T; Rommer P; Puchhammer-Stöckl E
Cell; 2023 Dec; 186(26):5705-5718.e13. PubMed ID: 38091993
[TBL] [Abstract][Full Text] [Related]
16. Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis.
Pender MP; Csurhes PA; Lenarczyk A; Pfluger CM; Burrows SR
J Neurol Neurosurg Psychiatry; 2009 May; 80(5):498-505. PubMed ID: 19015225
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus genotypes in multiple sclerosis.
Lindsey JW; Patel S; Zou J
Acta Neurol Scand; 2008 Feb; 117(2):141-4. PubMed ID: 18184350
[TBL] [Abstract][Full Text] [Related]
18. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.
Sargsyan SA; Shearer AJ; Ritchie AM; Burgoon MP; Anderson S; Hemmer B; Stadelmann C; Gattenlöhner S; Owens GP; Gilden D; Bennett JL
Neurology; 2010 Apr; 74(14):1127-35. PubMed ID: 20220124
[TBL] [Abstract][Full Text] [Related]
19. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.
Jilek S; Schluep M; Meylan P; Vingerhoets F; Guignard L; Monney A; Kleeberg J; Le Goff G; Pantaleo G; Du Pasquier RA
Brain; 2008 Jul; 131(Pt 7):1712-21. PubMed ID: 18550621
[TBL] [Abstract][Full Text] [Related]
20. Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
Otto C; Hofmann J; Ruprecht K
Med Hypotheses; 2016 Jun; 91():109-113. PubMed ID: 27142157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
